Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway

Xiang Hu, Ya-Qi Li, Qing-Guo Li, +3

Journal of Experimental & Clinical Cancer Research

ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer

Xiang Hu, Ya-Qi Li, Qing-Guo Li, +3

EBioMedicine

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer

Xiang Hu, Ya-Qi Li, Qing-Guo Li, +3

EBioMedicine

Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis

Xiang Hu, Ya-Qi Li, Qing-Guo Li, +3

The Oncologist

Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients

Xiang Hu, Ya-Qi Li, Qing-Guo Li, +3

Cellular Physiology and Biochemistry

Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers

Xiang Hu, Ya-Qi Li, Qing-Guo Li, +3

Frontiers in Immunology

Metastatic lymph node ratio can further stratify prognosis in rectal cancer patients treated with preoperative radiotherapy: a population-based analysis

Qing-Guo Li, Dawei Li, Changhua Zhuo, +2

Tumor Biology